Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Correction: Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer.

El-Kenawi A, Gatenbee C, Robertson-Tessi M, Bravo R, Dhillon J, Balagurunathan Y, Berglund A, Vishvakarma N, Ibrahim-Hashim A, Choi J, Luddy K, Gatenby R, Pilon-Thomas S, Anderson A, Ruffell B, Gillies R.

Br J Cancer. 2020 Mar;122(7):1118. doi: 10.1038/s41416-019-0710-4.

2.

Radiological semantics discriminate clinically significant grade prostate cancer.

Li Q, Lu H, Choi J, Gage K, Feuerlein S, Pow-Sang JM, Gillies R, Balagurunathan Y.

Cancer Imaging. 2019 Dec 3;19(1):81. doi: 10.1186/s40644-019-0272-y.

3.

Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer.

El-Kenawi A, Gatenbee C, Robertson-Tessi M, Bravo R, Dhillon J, Balagurunathan Y, Berglund A, Vishvakarma N, Ibrahim-Hashim A, Choi J, Luddy K, Gatenby R, Pilon-Thomas S, Anderson A, Ruffell B, Gillies R.

Br J Cancer. 2019 Oct;121(7):556-566. doi: 10.1038/s41416-019-0542-2. Epub 2019 Aug 16. Erratum in: Br J Cancer. 2020 Jan 14;:.

4.

Multi-window CT based Radiomic signatures in differentiating indolent versus aggressive lung cancers in the National Lung Screening Trial: a retrospective study.

Lu H, Mu W, Balagurunathan Y, Qi J, Abdalah MA, Garcia AL, Ye Z, Gillies RJ, Schabath MB.

Cancer Imaging. 2019 Jun 28;19(1):45. doi: 10.1186/s40644-019-0232-6.

5.

Quantitative Imaging features Improve Discrimination of Malignancy in Pulmonary nodules.

Balagurunathan Y, Schabath MB, Wang H, Liu Y, Gillies RJ.

Sci Rep. 2019 Jun 12;9(1):8528. doi: 10.1038/s41598-019-44562-z.

6.

Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors.

Parra NA, Lu H, Li Q, Stoyanova R, Pollack A, Punnen S, Choi J, Abdalah M, Lopez C, Gage K, Park JY, Kosj Y, Pow-Sang JM, Gillies RJ, Balagurunathan Y.

Oncotarget. 2019 Mar 12;10(21):2113. doi: 10.18632/oncotarget.26802. eCollection 2019 Mar 12.

7.

Explaining Deep Features Using Radiologist-Defined Semantic Features and Traditional Quantitative Features.

Paul R, Schabath M, Balagurunathan Y, Liu Y, Li Q, Gillies R, Hall LO, Goldgof DB.

Tomography. 2019 Mar;5(1):192-200. doi: 10.18383/j.tom.2018.00034.

8.

Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.

Stringfield O, Arrington JA, Johnston SK, Rognin NG, Peeri NC, Balagurunathan Y, Jackson PR, Clark-Swanson KR, Swanson KR, Egan KM, Gatenby RA, Raghunand N.

Tomography. 2019 Mar;5(1):135-144. doi: 10.18383/j.tom.2018.00052.

9.

Habitats in DCE-MRI to Predict Clinically Significant Prostate Cancers.

Parra NA, Lu H, Choi J, Gage K, Pow-Sang J, Gillies RJ, Balagurunathan Y.

Tomography. 2019 Mar;5(1):68-76. doi: 10.18383/j.tom.2018.00037.

10.

Semiautomated Measure of Abdominal Adiposity Using Computed Tomography Scan Analysis.

Srikumar T, Siegel EM, Gu Y, Balagurunathan Y, Garcia AL, Chen YA, Zhou JM, Zhao X, Gillies R, Clark W, Gamenthaler A, Choi J, Shibata D.

J Surg Res. 2019 May;237:12-21. doi: 10.1016/j.jss.2018.11.027. Epub 2019 Jan 14.

PMID:
30694786
11.

Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors.

Parra NA, Lu H, Li Q, Stoyanova R, Pollack A, Punnen S, Choi J, Abdalah M, Lopez C, Gage K, Park JY, Kosj Y, Pow-Sang JM, Gillies RJ, Balagurunathan Y.

Oncotarget. 2018 Dec 14;9(98):37125-37136. doi: 10.18632/oncotarget.26437. eCollection 2018 Dec 14. Erratum in: Oncotarget. 2019 Mar 12;10(21):2113. Parra, Andres N [corrected to Parra, N Andres].

12.

Delta radiomic features improve prediction for lung cancer incidence: A nested case-control analysis of the National Lung Screening Trial.

Cherezov D, Hawkins SH, Goldgof DB, Hall LO, Liu Y, Li Q, Balagurunathan Y, Gillies RJ, Schabath MB.

Cancer Med. 2018 Dec;7(12):6340-6356. doi: 10.1002/cam4.1852. Epub 2018 Dec 1.

13.

Representation of Deep Features using Radiologist defined Semantic Features.

Paul R, Liu Y, Li Q, Hall L, Goldgof D, Balagurunathan Y, Schabath M, Gillies R.

Proc Int Jt Conf Neural Netw. 2018 Jul;2018. doi: 10.1109/IJCNN.2018.8489440. Epub 2018 Sep 15.

14.

Erratum: Semi-automated pulmonary nodule interval segmentation using the NLST data.

Balagurunathan Y, Beers A, Kalpathy-Cramer J, McNitt-Gray M, Hadjiiski L, Zhao B, Zhu J, Yang H, Yip SSF, Aerts HJWL, Napel S, Cherezov D, Cha K, Chan HP, Flores C, Garcia A, Gillies R, Goldgof D.

Med Phys. 2018 Jun;45(6):2689-2690. doi: 10.1002/mp.12905. Epub 2018 Apr 24. No abstract available.

15.

Perfusion MR Imaging of Breast Cancer: Insights Using "Habitat Imaging".

Gillies RJ, Balagurunathan Y.

Radiology. 2018 Jul;288(1):36-37. doi: 10.1148/radiol.2018180271. Epub 2018 May 1. No abstract available.

PMID:
29714676
16.

Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas.

Liu Y, Kim J, Balagurunathan Y, Hawkins S, Stringfield O, Schabath MB, Li Q, Qu F, Liu S, Garcia AL, Ye Z, Gillies RJ.

Med Phys. 2018 Jun;45(6):2518-2526. doi: 10.1002/mp.12901. Epub 2018 Apr 29.

17.

Semi-automated pulmonary nodule interval segmentation using the NLST data.

Balagurunathan Y, Beers A, Kalpathy-Cramer J, McNitt-Gray M, Hadjiiski L, Zhao B, Zhu J, Yang H, Yip SSF, Aerts HJWL, Napel S, Cherezov D, Cha K, Chan HP, Flores C, Garcia A, Gillies R, Goldgof D.

Med Phys. 2018 Mar;45(3):1093-1107. doi: 10.1002/mp.12766. Epub 2018 Feb 19. Erratum in: Med Phys. 2018 Jun;45(6):2689-2690.

18.

Radial gradient and radial deviation radiomic features from pre-surgical CT scans are associated with survival among lung adenocarcinoma patients.

Tunali I, Stringfield O, Guvenis A, Wang H, Liu Y, Balagurunathan Y, Lambin P, Gillies RJ, Schabath MB.

Oncotarget. 2017 Oct 6;8(56):96013-96026. doi: 10.18632/oncotarget.21629. eCollection 2017 Nov 10.

19.

Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.

Li Q, Balagurunathan Y, Liu Y, Qi J, Schabath MB, Ye Z, Gillies RJ.

Clin Lung Cancer. 2018 Mar;19(2):148-156.e3. doi: 10.1016/j.cllc.2017.10.002. Epub 2017 Oct 13.

20.

CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.

Li Q, Kim J, Balagurunathan Y, Qi J, Liu Y, Latifi K, Moros EG, Schabath MB, Ye Z, Gillies RJ, Dilling TJ.

Radiat Oncol. 2017 Sep 25;12(1):158. doi: 10.1186/s13014-017-0892-y.

21.

Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Permuth JB, Chen DT, Yoder SJ, Li J, Smith AT, Choi JW, Kim J, Balagurunathan Y, Jiang K, Coppola D, Centeno BA, Klapman J, Hodul P, Karreth FA, Trevino JG, Merchant N, Magliocco A, Malafa MP, Gillies R.

Sci Rep. 2017 Sep 5;7(1):10484. doi: 10.1038/s41598-017-09754-5.

22.

Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI.

Chang YC, Ackerstaff E, Tschudi Y, Jimenez B, Foltz W, Fisher C, Lilge L, Cho H, Carlin S, Gillies RJ, Balagurunathan Y, Yechieli RL, Subhawong T, Turkbey B, Pollack A, Stoyanova R.

Sci Rep. 2017 Aug 29;7(1):9746. doi: 10.1038/s41598-017-09932-5.

23.

Radiologic Features of Small Pulmonary Nodules and Lung Cancer Risk in the National Lung Screening Trial: A Nested Case-Control Study.

Liu Y, Wang H, Li Q, McGettigan MJ, Balagurunathan Y, Garcia AL, Thompson ZJ, Heine JJ, Ye Z, Gillies RJ, Schabath MB.

Radiology. 2018 Jan;286(1):298-306. doi: 10.1148/radiol.2017161458. Epub 2017 Aug 24.

24.

Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy.

Li Q, Kim J, Balagurunathan Y, Liu Y, Latifi K, Stringfield O, Garcia A, Moros EG, Dilling TJ, Schabath MB, Ye Z, Gillies RJ.

Med Phys. 2017 Aug;44(8):4341-4349. doi: 10.1002/mp.12309. Epub 2017 Jun 24.

25.

A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?

Permuth JB, Choi JW, Chen DT, Jiang K, DeNicola G, Li JN, Coppola D, Centeno BA, Magliocco A, Balagurunathan Y, Merchant N, Trevino JG, Jeong D.

Cancer Biol Med. 2017 Feb;14(1):66-73. doi: 10.20892/j.issn.2095-3941.2017.0006.

26.

Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution.

Ibrahim-Hashim A, Robertson-Tessi M, Enriquez-Navas PM, Damaghi M, Balagurunathan Y, Wojtkowiak JW, Russell S, Yoonseok K, Lloyd MC, Bui MM, Brown JS, Anderson ARA, Gillies RJ, Gatenby RA.

Cancer Res. 2017 May 1;77(9):2242-2254. doi: 10.1158/0008-5472.CAN-16-2844. Epub 2017 Mar 1.

27.

Radiomics of Lung Nodules: A Multi-Institutional Study of Robustness and Agreement of Quantitative Imaging Features.

Kalpathy-Cramer J, Mamomov A, Zhao B, Lu L, Cherezov D, Napel S, Echegaray S, Rubin D, McNitt-Gray M, Lo P, Sieren JC, Uthoff J, Dilger SK, Driscoll B, Yeung I, Hadjiiski L, Cha K, Balagurunathan Y, Gillies R, Goldgof D.

Tomography. 2016 Dec;2(4):430-437. doi: 10.18383/j.tom.2016.00235.

28.

Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels.

Shafiq-Ul-Hassan M, Zhang GG, Latifi K, Ullah G, Hunt DC, Balagurunathan Y, Abdalah MA, Schabath MB, Goldgof DG, Mackin D, Court LE, Gillies RJ, Moros EG.

Med Phys. 2017 Mar;44(3):1050-1062. doi: 10.1002/mp.12123.

29.

Deep Feature Transfer Learning in Combination with Traditional Features Predicts Survival Among Patients with Lung Adenocarcinoma.

Paul R, Hawkins SH, Balagurunathan Y, Schabath MB, Gillies RJ, Hall LO, Goldgof DB.

Tomography. 2016 Dec;2(4):388-395. doi: 10.18383/j.tom.2016.00211.

30.

Improving malignancy prediction through feature selection informed by nodule size ranges in NLST.

Cherezov D, Hawkins S, Goldgof D, Hall L, Balagurunathan Y, Gillies RJ, Schabath MB.

Conf Proc IEEE Int Conf Syst Man Cybern. 2016 Oct;2016:001939-1944. doi: 10.1109/SMC.2016.7844523. Epub 2017 Feb 9.

31.

Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules.

Liu Y, Balagurunathan Y, Atwater T, Antic S, Li Q, Walker RC, Smith GT, Massion PP, Schabath MB, Gillies RJ.

Clin Cancer Res. 2017 Mar 15;23(6):1442-1449. doi: 10.1158/1078-0432.CCR-15-3102. Epub 2016 Sep 23.

32.

Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.

Schabath MB, Massion PP, Thompson ZJ, Eschrich SA, Balagurunathan Y, Goldof D, Aberle DR, Gillies RJ.

PLoS One. 2016 Aug 10;11(8):e0159880. doi: 10.1371/journal.pone.0159880. eCollection 2016.

33.

Prostate cancer radiomics and the promise of radiogenomics.

Stoyanova R, Takhar M, Tschudi Y, Ford JC, Solórzano G, Erho N, Balagurunathan Y, Punnen S, Davicioni E, Gillies RJ, Pollack A.

Transl Cancer Res. 2016 Aug;5(4):432-447.

34.

Predicting Malignant Nodules from Screening CT Scans.

Hawkins S, Wang H, Liu Y, Garcia A, Stringfield O, Krewer H, Li Q, Cherezov D, Gatenby RA, Balagurunathan Y, Goldgof D, Schabath MB, Hall L, Gillies RJ.

J Thorac Oncol. 2016 Dec;11(12):2120-2128. doi: 10.1016/j.jtho.2016.07.002. Epub 2016 Jul 13. Erratum in: J Thorac Oncol. 2018 Feb;13(2):280-281.

35.

Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.

Liu Y, Kim J, Balagurunathan Y, Li Q, Garcia AL, Stringfield O, Ye Z, Gillies RJ.

Clin Lung Cancer. 2016 Sep;17(5):441-448.e6. doi: 10.1016/j.cllc.2016.02.001. Epub 2016 Feb 16.

36.

CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.

Liu Y, Kim J, Qu F, Liu S, Wang H, Balagurunathan Y, Ye Z, Gillies RJ.

Radiology. 2016 Jul;280(1):271-80. doi: 10.1148/radiol.2016151455. Epub 2016 Mar 3.

37.

Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value.

Wang H, Schabath MB, Liu Y, Stringfield O, Balagurunathan Y, Heine JJ, Eschrich SA, Ye Z, Gillies RJ.

Clin Lung Cancer. 2016 Jul;17(4):271-8. doi: 10.1016/j.cllc.2015.11.002. Epub 2015 Nov 12.

38.

Intermittent hypoxia selects for genotypes and phenotypes that increase survival, invasion, and therapy resistance.

Verduzco D, Lloyd M, Xu L, Ibrahim-Hashim A, Balagurunathan Y, Gatenby RA, Gillies RJ.

PLoS One. 2015 Mar 26;10(3):e0120958. doi: 10.1371/journal.pone.0120958. eCollection 2015.

39.

Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma.

Grove O, Berglund AE, Schabath MB, Aerts HJ, Dekker A, Wang H, Velazquez ER, Lambin P, Gu Y, Balagurunathan Y, Eikman E, Gatenby RA, Eschrich S, Gillies RJ.

PLoS One. 2015 Mar 4;10(3):e0118261. doi: 10.1371/journal.pone.0118261. eCollection 2015.

40.

Test-retest reproducibility analysis of lung CT image features.

Balagurunathan Y, Kumar V, Gu Y, Kim J, Wang H, Liu Y, Goldgof DB, Hall LO, Korn R, Zhao B, Schwartz LH, Basu S, Eschrich S, Gatenby RA, Gillies RJ.

J Digit Imaging. 2014 Dec;27(6):805-23. doi: 10.1007/s10278-014-9716-x.

41.

Mechanisms of buffer therapy resistance.

Bailey KM, Wojtkowiak JW, Cornnell HH, Ribeiro MC, Balagurunathan Y, Hashim AI, Gillies RJ.

Neoplasia. 2014 Apr;16(4):354-64.e1-3. doi: 10.1016/j.neo.2014.04.005.

42.

Reproducibility and Prognosis of Quantitative Features Extracted from CT Images.

Balagurunathan Y, Gu Y, Wang H, Kumar V, Grove O, Hawkins S, Kim J, Goldgof DB, Hall LO, Gatenby RA, Gillies RJ.

Transl Oncol. 2014 Feb 1;7(1):72-87. eCollection 2014 Feb.

43.

Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.

Zhou M, Hall L, Goldgof D, Russo R, Balagurunathan Y, Gillies R, Gatenby R.

Transl Oncol. 2014 Feb 1;7(1):5-13. eCollection 2014 Feb.

44.

Laboratory intercomparison of gene expression assays.

Badie C, Kabacik S, Balagurunathan Y, Bernard N, Brengues M, Faggioni G, Greither R, Lista F, Peinnequin A, Poyot T, Herodin F, Missel A, Terbrueggen B, Zenhausern F, Rothkamm K, Meineke V, Braselmann H, Beinke C, Abend M.

Radiat Res. 2013 Aug;180(2):138-48. doi: 10.1667/RR3236.1. Epub 2013 Jul 25.

45.

Comparison of established and emerging biodosimetry assays.

Rothkamm K, Beinke C, Romm H, Badie C, Balagurunathan Y, Barnard S, Bernard N, Boulay-Greene H, Brengues M, De Amicis A, De Sanctis S, Greither R, Herodin F, Jones A, Kabacik S, Knie T, Kulka U, Lista F, Martigne P, Missel A, Moquet J, Oestreicher U, Peinnequin A, Poyot T, Roessler U, Scherthan H, Terbrueggen B, Thierens H, Valente M, Vral A, Zenhausern F, Meineke V, Braselmann H, Abend M.

Radiat Res. 2013 Aug;180(2):111-9. doi: 10.1667/RR3231.1. Epub 2013 Jul 17.

46.

Acidity generated by the tumor microenvironment drives local invasion.

Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, Johnson J, Gatenby RA, Gillies RJ.

Cancer Res. 2013 Mar 1;73(5):1524-35. doi: 10.1158/0008-5472.CAN-12-2796. Epub 2013 Jan 3.

47.

Radiomics: the process and the challenges.

Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, Forster K, Aerts HJ, Dekker A, Fenstermacher D, Goldgof DB, Hall LO, Lambin P, Balagurunathan Y, Gatenby RA, Gillies RJ.

Magn Reson Imaging. 2012 Nov;30(9):1234-48. doi: 10.1016/j.mri.2012.06.010. Epub 2012 Aug 13. Review.

48.

Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.

Ariazi EA, Cunliffe HE, Lewis-Wambi JS, Slifker MJ, Willis AL, Ramos P, Tapia C, Kim HR, Yerrum S, Sharma CG, Nicolas E, Balagurunathan Y, Ross EA, Jordan VC.

Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):18879-86. doi: 10.1073/pnas.1115188108. Epub 2011 Oct 19.

49.

Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray.

Morse DL, Balagurunathan Y, Hostetter G, Trissal M, Tafreshi NK, Burke N, Lloyd M, Enkemann S, Coppola D, Hruby VJ, Gillies RJ, Han H.

Biochem Pharmacol. 2010 Sep 1;80(5):748-54. doi: 10.1016/j.bcp.2010.05.018. Epub 2010 May 25.

50.

Identification of pancreatic cancer-specific cell-surface markers for development of targeting ligands.

Morse DL, Hostetter G, Balagurunathan Y, Gillies RJ, Han H.

Methods Mol Biol. 2010;624:195-210. doi: 10.1007/978-1-60761-609-2_13.

Supplemental Content

Loading ...
Support Center